Nonetheless, the good prognosis of AML with recurrent genetic abnormalities CBF-AML is modified by other mutations, such as Fms-Like Tyrosine kinase 3 (FLT3)-Internal tandem Duplication (ITD), demonstrating, again, the usefulness of NGS analysis [13]. Here, FLT3 is linked to acute myeloid leukemia.